Editorial (Thematic Issue: Current Overview of Anti-Angiogenic Therapies for Patients with Epithelial Ovarian Cancer)
Journal:
Current Angiogenesis (Discontinued)
Volume:
3
Page:
175-178
Author(s):
Samir A. Farghaly
Ovarian Cancer - Angiogenesis and Targeted Therapy
Journal:
Current Angiogenesis (Discontinued)
Volume:
3
Page:
215-230
Author(s):
Kristsanamon Rittiluechai, Naiyarat Prasongsuk, Vincent Vinh-Hung and Claire Verschraegen
Anti-angiogenic Therapy and Induction of Blood Vessel Normalization in the Treatment of Ovarian Cancer
Journal:
Current Angiogenesis (Discontinued)
Volume:
3
Page:
203-214
Author(s):
Simone Ten Kortenaar, Jack Lawler and Jim Petrik
Trebananib (AMG 386): A Non-VEGF Antiangiogenesis Option in Women with Ovarian Cancer
Journal:
Current Angiogenesis (Discontinued)
Volume:
3
Page:
193-202
Author(s):
Al Wadi Khalid and Ghatage Prafull
Novel Therapeutic Strategies For Angiogenesis Inhibition In Recurrent Ovarian Cancer
Journal:
Current Angiogenesis (Discontinued)
Volume:
3
Page:
179-192
Author(s):
Victoria L. Chiou, Elise C. Kohn, Nicole Davarpanah and Jung-Min Lee
Notch Signaling in Cancer: Rationale and Strategies for Targeting
Journal:
Current Cancer Drug Targets
Volume:
15
Page:
364-374
Author(s):
Aisha Alketbi and Samir Attoub
Cancer Stem-Cells Patents in the Context of their Therapeutic Purposes: Exploring the Latest Trends (2011-2015)
Journal:
Recent Patents on Regenerative Medicine
Volume:
5
Page:
55-64
Author(s):
Pablo Alvarez, Arturo Arguello, Amelia E. Aranega, Celia Velez, Antonia Aranega, Carlos Gonzalez and Jose C. Prados-Salazar
Immune Checkpoint Inhibition: Therapeutic Implications in Epithelial Ovarian Cancer
Journal:
Recent Patents on Anti-Cancer Drug Discovery
Volume:
10
Page:
133-144
Author(s):
Teresa C. Longoria and Ramez N. Eskander
Co-targeting EGFR and Autophagy Impairs Ovarian Cancer Cell Survival during Detachment from the ECM
Journal:
Current Cancer Drug Targets
Volume:
15
Page:
215-226
Author(s):
Zongyuan Yang, Yi Liu, Xiao Wei, Xiaoshui Zhou, Cheng Gong, Taoran Zhang, Ping Jin, Sen Xu, Ding Ma and Qinglei Gao
Low Dose Decitabine Combined with Taxol and Platinum Chemotherapy to Treat Refractory/Recurrent Ovarian Cancer: An Open-Label, Single-Arm, Phase I/II Study
Journal:
Current Protein & Peptide Science
Volume:
16
Page:
329-336
Author(s):
Xiaoyu Fu, Yan Zhang, Xiaohui Wang, Meixia Chen, Yao Wang, Jing Nie, Yuanguang Meng and Weidong Han